JavaScript is disabled in your browser. You can still read and search, but features like search previews, menus, and forms may not work until it's enabled.
Skip to content
Characteristics
Peer reviewed
Topics
LSD
Abstract
Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
Create a free account to bookmark articles, vote on relevance, generate your own syntheses, and join the discussion.
Related reading
ChemInform Abstract: Improvements to the Synthesis of Psilocybin and a Facile Method for Preparing the O‐Acetyl Prodrug of Psilocin.
ChemInform
August 17, 1999
2 citations
ChemInform Abstract: Abbreviated Ibogaine Congeners. Synthesis and Reactions of Tropan‐3‐yl‐ 2‐ and ‐3‐indoles. Investigation of an Unusual Isomerization of 2‐ Substituted Indoles Using Computational and Spectroscopic Techniques.
ChemInform
October 4, 1994
ChemInform Abstract: Palladium‐Catalyzed Synthesis of Tryptamines and Tryptamine Homologues: Synthesis of Psilocin.
ChemInform
March 2, 2010
ChemInform Abstract: Total Synthesis of the Hallucinogenic Neoclerodane Diterpenoid Salvinorin A.
ChemInform
August 26, 2008
ChemInform Abstract: 2,3‐ and 4,5‐Secodopa, the Biosynthetic Intermediates Generated from L‐ Dopa by an Enzyme System Extracted from the Fly Agaric, Amanita muscaria L., and Their Spontaneous Conversion to Muscaflavin and Betalamic Acid, Respectively, and Betalains.
ChemInform
April 23, 1991
For research and education, not medical advice. Talk with a clinician about your own care.
© 2026 The Consciousness Library
Support Our Mission
Choose your preferred way to support The Consciousness Library's work in advancing consciousness research.
A registered 501(c)(3) nonprofit; donations are tax-deductible in the US.
Donations are processed by Mindscape Collective, our legal entity, and may appear that way on your statement.